Cargando…

Anti-Hepatitis B Virus X Protein in Sera Is One of the Markers of Development of Liver Cirrhosis and Liver Cancer Mediated by HBV

Hepatitis B virus X protein (HBx) plays a crucial role in the development of hepatocellular carcinoma (HCC). However, the significance of circulating antibody to hepatitis B virus X antigen (anti-HBx) in sera remains unclear. In the present study, we examined the titers of anti-HBx (IgG) in the sera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Hang, Wu, Lian-Ying, Zhang, Shuai, Qiu, Li-Yan, Li, Nan, Zhang, Xuan, Zhang, Xue-Zhi, Shan, Chang-Liang, Ye, Li-Hong, Zhang, Xiao-Dong
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2738860/ https://www.ncbi.nlm.nih.gov/pubmed/19746176 http://dx.doi.org/10.1155/2009/289068

Ejemplares similares

Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma
por: Wang, Xin, et al.
Publicado: (2019)

Quantification of Intact O-Glycopeptides on Haptoglobin in Sera of Patients With Hepatocellular Carcinoma and Liver Cirrhosis
por: Shu, Hong, et al.
Publicado: (2021)

Risk factors associated with hepatic osteopathy in HBV related cirrhosis measured by liver stiffness: An Observational study
por: Zhang, Wei, et al.
Publicado: (2019)

HBV infection-induced liver cirrhosis development in dual-humanised mice with human bone mesenchymal stem cell transplantation
por: Yuan, Lunzhi, et al.
Publicado: (2019)

Changes in intestinal microbiota of HBV-associated liver cirrhosis with/without hepatic encephalopathy
por: Hua, Xiaoli, et al.
Publicado: (2022)

Role of precipitants in transition of acute decompensation to acute-on-chronic liver failure in patients with HBV-related cirrhosis
por: Wang, Tongyu, et al.
Publicado: (2022)

HBV-related acute-on-chronic liver failure with underlying chronic hepatitis has superior survival compared to cirrhosis
por: Liu, Xiaohui, et al.
Publicado: (2021)

Serum Liver Fibrosis Markers in the Prognosis of Liver Cirrhosis: A Prospective Observational Study
por: Qi, Xingshun, et al.
Publicado: (2016)

Enhanced therapeutic effects of umbilical cord mesenchymal stem cells after prolonged treatment for HBV-related liver failure and liver cirrhosis
por: Jia, Yifan, et al.
Publicado: (2020)

Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma
por: Gong, Wen-Feng, et al.
Publicado: (2017)

Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis
por: Xia, Xiaoxue, et al.
Publicado: (2018)

The impact of recipient age on the effects of umbilical cord mesenchymal stem cells on HBV-related acute-on-chronic liver failure and liver cirrhosis
por: Zhang, Ka, et al.
Publicado: (2021)

Association between liver cirrhosis and estimated glomerular filtration rates in patients with chronic HBV infection
por: Wang, Dexin, et al.
Publicado: (2020)

The role of exosomes in hepatitis, liver cirrhosis and hepatocellular carcinoma
por: Shen, Jiliang, et al.
Publicado: (2017)

Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers.
por: White, Y. S., et al.
Publicado: (1990)

FibroBox: a novel noninvasive tool for predicting significant liver fibrosis and cirrhosis in HBV infected patients
por: Lu, Xiao-Jie, et al.
Publicado: (2020)

Hepatic parenchyma and vascular blood flow changes after TIPS with spectral CT iodine density in HBV-related liver cirrhosis
por: Wang, Lei, et al.
Publicado: (2021)

Correlation of Serum Cardiac Markers with Acute Decompensating Events in Liver Cirrhosis
por: Li, Miaomiao, et al.
Publicado: (2020)

Single-cell landscape of immune cells in human livers affected by HBV-related cirrhosis
por: Bai, Qingquan, et al.
Publicado: (2023)

Differential expression and significance of 5-hydroxymethylcytosine modification in hepatitis B virus carriers and patients with liver cirrhosis and liver cancer
por: Li, Yue-Cui, et al.
Publicado: (2023)

Detection of MAGE‐4 Protein in the Sera of Patients with Hepatitis‐C Virus‐associated Hepatocellular Carcinoma and Liver Cirrhosis
por: Tsuzurahara, Shin‐ichi, et al.
Publicado: (1997)

Association between lymphocyte-to-monocyte ratio (LMR) and the mortality of HBV-related liver cirrhosis: a retrospective cohort study
por: Zhang, Jie, et al.
Publicado: (2015)

Red cell distribution width-to-lymphocyte ratio: A novel predictor for HBV-related liver cirrhosis
por: Zhang, Xueyan, et al.
Publicado: (2020)

An MLP Classifier for Prediction of HBV-Induced Liver Cirrhosis Using Routinely Available Clinical Parameters
por: Cao, Yuan, et al.
Publicado: (2013)

Two Classifiers Based on Serum Peptide Pattern for Prediction of HBV-Induced Liver Cirrhosis Using MALDI-TOF MS
por: Cao, Yuan, et al.
Publicado: (2013)

Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
por: Chen, Qingling, et al.
Publicado: (2023)

Gut microbiota as prognosis markers for patients with HBV-related acute-on-chronic liver failure
por: Wang, Ke, et al.
Publicado: (2021)

Diagnostic and Prognostic Markers in Liver Cirrhosis
por: Augustin, Salvador, et al.
Publicado: (2011)

Bacterial translocation markers in liver cirrhosis
por: Alexopoulou, Alexandra, et al.
Publicado: (2017)

Evaluation of the Alpha-Fetoprotein Model for Predicting Recurrence and Survival in Patients With Hepatitis B Virus (HBV)–Related Cirrhosis Who Received Liver Transplantation for Hepatocellular Carcinoma
por: Ren, Ao, et al.
Publicado: (2020)

An Intronic Variant in the GRP78, a Stress-Associated Gene, Improves Prediction for Liver Cirrhosis in Persistent HBV Carriers
por: Zhu, Xiao, et al.
Publicado: (2011)

Hepatitis B virus (HBV) X gene mutations and their association with liver disease progression in HBV-infected patients
por: Al-Qahtani, Ahmed A., et al.
Publicado: (2017)

Bacterial Infections Confer a Risk of Progression to Acute-on-Chronic Liver Failure in Patients with HBV-Related Compensated Cirrhosis During Severe Hepatitis Flares
por: Chu, Jun, et al.
Publicado: (2022)

Platelet‐to‐white blood cell ratio: A novel and promising prognostic marker for HBV‐associated decompensated cirrhosis
por: Zhang, JinFei, et al.
Publicado: (2020)

Reestablishment of Active Immunity against HBV Graft Reinfection after Liver Transplantation for HBV-Related End Stage Liver Disease
por: Lu, Shi-Chun, et al.
Publicado: (2014)

Therapeutic effect of autologous bone marrow cells injected into the liver under the guidance of B‑ultrasound in the treatment of HBV‑related decompensated liver cirrhosis
por: Li, Lei, et al.
Publicado: (2022)

Development and validation of a prognostic nomogram for decompensated liver cirrhosis
por: Zhang, Wang, et al.
Publicado: (2022)

The gut–liver axis in immune remodeling of hepatic cirrhosis
por: Guan, Huayu, et al.
Publicado: (2022)

Association of C-type lectin-like receptor 2 and galectin-1 with portal vein system thrombosis in HBV-related liver cirrhosis
por: Zhang, Yiyan, et al.
Publicado: (2023)

Markers of cardiac injury in patients with liver cirrhosis
por: Šimić, Stjepan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vgbupurg54bk2csnv6bup385g9